Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) Ligand
about
Small Molecules for Active Targeting in Cancer.Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.Ligand-decorated click polypeptide derived nanoparticles for targeted drug delivery applicationsSynthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline.Copper-Free 'Click' Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia.
P2860
Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) Ligand
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Selective Tumor Targeting of D ...... inin 2 Receptor (CCK2R) Ligand
@ast
Selective Tumor Targeting of D ...... inin 2 Receptor (CCK2R) Ligand
@en
type
label
Selective Tumor Targeting of D ...... inin 2 Receptor (CCK2R) Ligand
@ast
Selective Tumor Targeting of D ...... inin 2 Receptor (CCK2R) Ligand
@en
prefLabel
Selective Tumor Targeting of D ...... inin 2 Receptor (CCK2R) Ligand
@ast
Selective Tumor Targeting of D ...... inin 2 Receptor (CCK2R) Ligand
@en
P2093
P2860
P1476
Selective Tumor Targeting of D ...... inin 2 Receptor (CCK2R) Ligand
@en
P2093
Charity Wayua
Karson S Putt
P2860
P304
P356
10.1021/ACS.MOLPHARMACEUT.5B00218
P407
P577
2015-06-16T00:00:00Z